The global microbial identification industry is expected to be worth US$ 3.7 billion in 2022, and to grow at a CAGR of 11.3% between 2022 and 2032, to be worth around US$ 10.7 billion by 2032. Rising demand for microbial identification products across various end-user sectors such as pharmaceutical and biotechnology.
One of the giants in scientific discovery was Antonie van Leeuwenhoek, who in 1677 published the first document on micro-organisms. He is universally acknowledged as the father of microbiology. He even developed his own microscope, which was state-of-the-art at the time but very simple by today’s standards.
A recent study in "Microorganisms" delves into the relationship between the microbiome and biliary tract cancer, revealing distinct microbial compositions in patients compared to healthy individuals. This research highlights potential diagnostic biomarkers and suggests that altering gut microbial composition might enhance responses to cancer immunotherapy.